Bids Are Invited For Acquisition Of Influenza Vaccine And Medicines.

Sodium Chloride Concentration: 0.9%, Pharmaceutical Form: Injectable Solution, Additional Feature: Closed System, Additional Features 1: Pvc-Free Bag/Fial 0.9% Sodium Chloride Solution - Physiological Serum 250 Ml, 9% - Physiological Serum 150 Ml, Lidocaine Composition: In Form Hydrochloride, Associated With Epinephrine, Concentration: 2% + 0.02%, Physical Form: Injectable Solution, Use: Veterinary Use Injectable Local Anesthetic Lidocaine 2% With Adrenaline (Epinephrine) 1:100,000 In Glass Tubesbox With 50 Glass Tubes Of 1.8 Ml., Pharmaceutical Form: Solution Sterile Non-Injectable Physiological Serum 09%, Bottle With Drip Nozzle 500 Ml, Chlorhexidine Digluconate Concentration: 0.12%, Pharmaceutical Form: Chlorhexidine Gluconate Mouthwash 0.12% (Alcohol Free)Alcohol Free.Bottle With At Least 1 Liter., 04/24/2026 - 15:42:24, 24/04/2026 - 15:42:25, Hydrogen Peroxide (Hydrogen Peroxide) Type: 10 Volumes Gentle, Paraben Free, Dermatologically Tested. 200 Ml., Benzocaine Concentration: 20%, Use: Topical Anesthetic Gel Topical Benzocaine 20%Pot With 12 Grams., Sodium Bicarbonate Presentation: Sodium Bicarbonate Powder For Prophylaxisbottle With 200 Grams., Polymyxin B Composition: Associated With Neomycin And Hydrocortisone, Concentration: 10,000 Ui/Ml + 5 Mg/Ml + 10, Pharmaceutical Form: Otological Suspension Otological Suspension Composed Of Hydrocortisone, Neomycin Sulfate And Polymyxin B Sulfate (Otosporin® Type Medication) I. Packaging Containing 10 Ml., Ethyl Alcohol Type: Hydrated, Alcoholic Content: 70%_(70°Gl), Presentation: 70% Liquid Alcohol Liquid 1000 Ml, Chlorhexidine Digluconate Dosage: 2%, Application: 2% Chlorhexidine Topical Solution (Solution) Bottle With At Least 100 Ml., Prilocaine Composition: Associated With Felipressin, Dosage: 3% + 0.03Ui/Ml, Presentation: Injectable Local Anesthetic Injectable Prilocaine 3% With Felipressinbox With 50 Glass Tubes Of 1, Vaccine Composition: Tetravalent Influenza, Type: Fragmented, Inactivated, Pharmaceutical Form: Injectable Suspension Tetravalent Influenza Vaccine, According To The Strains Defined By Anvisa Through Anvisa Normative Instruction No. 408, Of 11/24/2025, To Know::A) A Virus Similar To The Influenza Virus A/Missouri/11/2025 (H1n1)Pdm09; B) A Virus Similar To The Virus